|Mr. Jay T. Flatley||Chairman & Acting CEO||1.03M||N/A||1953|
|Mr. Zachariah Serber Ph.D.||Co-Founder, Chief Science Officer & Director||353.49k||N/A||1975|
|Ms. Enakshi Singh||Chief Financial Officer||390.3k||N/A||1978|
|Mr. Dmitriy Ryaboy||Chief Technology Officer||N/A||N/A||N/A|
|Ms. Mina Kim||Corp. Sec. & Chief Legal Officer||N/A||N/A||1974|
|Mike Dulin||Director of Communications||N/A||N/A||N/A|
|Ms. Judy Gilbert||Chief People Officer||N/A||N/A||N/A|
|Ms. Aindrea Campbell||Chief Manufacturing Officer||N/A||N/A||N/A|
|Mr. Lincoln Germain||Chief Commercial Officer||N/A||N/A||N/A|
|Mr. Subodh S. Deshmukh||Chief Devel. Officer||N/A||N/A||N/A|
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.
Zymergen Inc.’s ISS governance QualityScore as of 1 June 2022 is 9. The pillar scores are Audit: 9; Board: 8; Shareholder rights: 7; Compensation: 10.